UW Clinical Hematology and Transfusion Medicine Research Career Development Program (K12)
This award supports career development in clinical research in benign hematology and transfusion medicine. Benign hematology (as defined by the NIH) includes studies in hemostasis and classical benign hematology, as well as MDS and myeloproliferative disorders, but not CLL or leukemia. Studies of cardiovascular and cerebrovascular thromboembolic diseases are specifically excluded from funding. The grant provides resources (some linked to the UW Institute of Translational Health Sciences (ITHS)), so that our scholars can train in the way most optimal for their career development.
This grant is for CLINICAL RESEARCH, which is defined broadly to include clinical trials and studies, cost-efficacy and outcome studies, as well as studies of disease pathogenesis using human samples.
Applicants must have a faculty position (e.g., Acting Instructor) at the time that their funding initiates. The typical scholar will have just completed his/her fellowship training in adult or pediatric hematology, transfusion medicine, or a related field. K12 support is generally for 2 years. PhDs are technically eligible provided their career goals are benign hematology clinical research. Because we are at the end of our funding cycle and it is unlikely that NHLBI will continue to fund K12 efforts, this year's competition will be for 1 year of support as the grant cycle is ending.
We can also support more senior individuals such as an Assistant Professor who would like protected time to develop or refine credentials in clinical research (or, for example, obtain an MPH degree). We intend to use this grant creatively to maximally benefit our applicants.
We will thus judge our success by whether our scholars obtain K23 awards, K08 awards or other grant funding; whether they present their research findings at national meetings (such as ASH); whether they publish their results in prominent journals; and most importantly, whether they obtain “tenure track” or equivalent academic positions at UW or elsewhere. Please note that although K23 and K08 support is limited to 5 years, the NIH allows a 6-year total for K support. Thus, we envision that after 1 or 2 years of K12 funding, the typical scholar would begin K23 or K08 funding for 5 or 4 years, respectively.
Funding for each scholar is similar to other K awards and includes $100,000/y for salary support and the requirement that he/she spend at minimum 75% effort on grant activities. Up to $30,000 is provided each year for supplies/technician or research nurse assistance/statistical services/travel/tuition, etc. Notably, we can also provide 2% FTE (subject to the NIH salary rules) of salary and benefits support to the primary mentor. The scholar and mentor must attend the annual K12 trainees meeting.
Dr. Janis Abkowitz (PI), Dr. José López and Dr. Barbara Konkle (Co-PI’s) are happy to speak directly to potential applicants or mentors. Dr. Abkowitz can be reached by telephone at 206-685-7877 or by e-mail at email@example.com, Dr. López can be reached through his assistant at 206-568-2244 or by e-mail at joselbloodworksnw.org, and Dr. Konkle can be reached through her assistant at 206-689-6192 or by e-mail at BarbaraK@bloodworksnw.org.
To be eligible for this program, you must:
You are ineligible if you:
Timing of Application Process
Your application must be received by September 22, 2016.
An important component of this application will be your personal interview with K12 faculty members. Interviews will be conducted in late September to early October 2016.
The selection committee intends to notify applicants of funding decisions by late October 2016. The K12 fellowship will begin between January 1, 2017 and May 31, 2017. Funds will be available for 1 year's support.
An application form is available here. Please send all materials electronically to Dr. Janis Abkowitz c/o Allan Dimaunahan (firstname.lastname@example.org), UW Benign Hematology and Transfusion Medicine Clinical Research Career Development Program (K12).